Literature DB >> 11266299

Active bacterial core surveillance of the emerging infections program network.

A Schuchat1, T Hilger, E Zell, M M Farley, A Reingold, L Harrison, L Lefkowitz, R Danila, K Stefonek, N Barrett, D Morse, R Pinner.   

Abstract

Active Bacterial Core surveillance (ABCs) is a collaboration between the Centers for Disease Control and Prevention and several state health departments and universities participating in the Emerging Infections Program Network. ABCs conducts population-based active surveillance, collects isolates, and performs studies of invasive disease caused by Streptococcus pneumoniae, group A and group B Streptococcus, Neisseria meningitidis, and Haemophilus influenzae for a population of 17 to 30 million. These pathogens caused an estimated 97,000 invasive cases, resulting in 10,000 deaths in the United States in 1998. Incidence rates of these pathogens are described. During 1998, 25% of invasive pneumococcal infections in ABCs areas were not susceptible to penicillin, and 13.3% were not susceptible to three classes of antibiotics. In 1998, early-onset group B streptococcal disease had declined by 65% over the previous 6 years. More information on ABCs is available at www.cdc.gov/ncidod/dbmd/abcs. ABCs specimens will soon be available to researchers through an archive.

Entities:  

Mesh:

Year:  2001        PMID: 11266299      PMCID: PMC2631675          DOI: 10.3201/eid0701.010114

Source DB:  PubMed          Journal:  Emerg Infect Dis        ISSN: 1080-6040            Impact factor:   6.883


  28 in total

1.  Cigarette smoking and invasive pneumococcal disease. Active Bacterial Core Surveillance Team.

Authors:  J P Nuorti; J C Butler; M M Farley; L H Harrison; A McGeer; M S Kolczak; R F Breiman
Journal:  N Engl J Med       Date:  2000-03-09       Impact factor: 91.245

2.  Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis.

Authors:  S J Schrag; S Zywicki; M M Farley; A L Reingold; L H Harrison; L B Lefkowitz; J L Hadler; R Danila; P R Cieslak; A Schuchat
Journal:  N Engl J Med       Date:  2000-01-06       Impact factor: 91.245

3.  Group B streptococci: the new challenge in neonatal infections.

Authors:  G H McCracken
Journal:  J Pediatr       Date:  1973-04       Impact factor: 4.406

Review 4.  Streptococcal puerperal sepsis and obstetric infections: a historical perspective.

Authors:  D Charles; B Larsen
Journal:  Rev Infect Dis       Date:  1986 May-Jun

5.  A half century of neonatal sepsis at Yale: 1928 to 1978.

Authors:  R M Freedman; D L Ingram; I Gross; R A Ehrenkranz; J B Warshaw; R S Baltimore
Journal:  Am J Dis Child       Date:  1981-02

6.  Effects of hospital policies based on 1996 group B streptococcal disease consensus guidelines. The Active Bacterial Core Surveillance Team.

Authors:  S H Factor; C G Whitney; S S Zywicki; A Schuchat
Journal:  Obstet Gynecol       Date:  2000-03       Impact factor: 7.661

7.  Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997.

Authors:  D R Feikin; A Schuchat; M Kolczak; N L Barrett; L H Harrison; L Lefkowitz; A McGeer; M M Farley; D J Vugia; C Lexau; K R Stefonek; J E Patterson; J H Jorgensen
Journal:  Am J Public Health       Date:  2000-02       Impact factor: 9.308

Review 8.  Pneumococcal resistance to antibiotics.

Authors:  K P Klugman
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

9.  Changing epidemiology of group A streptococcal infection in the USA.

Authors:  B Schwartz; R R Facklam; R F Breiman
Journal:  Lancet       Date:  1990-11-10       Impact factor: 79.321

10.  Tracking drug-resistant Streptococcus pneumoniae in Oregon: an alternative surveillance method.

Authors:  A E Chin; K Hedberg; P R Cieslak; M Cassidy; K R Stefonek; D W Fleming
Journal:  Emerg Infect Dis       Date:  1999 Sep-Oct       Impact factor: 6.883

View more
  69 in total

1.  Immunogenicity of a 26-valent group A streptococcal vaccine.

Authors:  Mary C Hu; Michael A Walls; Steven D Stroop; Mark A Reddish; Bernard Beall; James B Dale
Journal:  Infect Immun       Date:  2002-04       Impact factor: 3.441

2.  Changing disparities in invasive pneumococcal disease by socioeconomic status and race/ ethnicity in Connecticut, 1998-2008.

Authors:  Kristen Soto; Susan Petit; James L Hadler
Journal:  Public Health Rep       Date:  2011 Sep-Oct       Impact factor: 2.792

3.  Adherence to perinatal group B streptococcal prevention guidelines.

Authors:  William P Goins; Thomas R Talbot; William Schaffner; Kathryn M Edwards; Allen S Craig; Stephanie J Schrag; Melissa K Van Dyke; Marie R Griffin
Journal:  Obstet Gynecol       Date:  2010-06       Impact factor: 7.661

Review 4.  Interaction of neonatal phagocytes with group B streptococcus: recognition and response.

Authors:  Philipp Henneke; Reinhard Berner
Journal:  Infect Immun       Date:  2006-06       Impact factor: 3.441

5.  Effect of concentrated ambient particles on macrophage phagocytosis and killing of Streptococcus pneumoniae.

Authors:  Hongwei Zhou; Lester Kobzik
Journal:  Am J Respir Cell Mol Biol       Date:  2006-11-01       Impact factor: 6.914

6.  Solution structure of choline binding protein A, the major adhesin of Streptococcus pneumoniae.

Authors:  Rensheng Luo; Beth Mann; William S Lewis; Arthur Rowe; Richard Heath; Michael L Stewart; Agnes E Hamburger; Siva Sivakolundu; Eilyn R Lacy; Pamela J Bjorkman; Elaine Tuomanen; Richard W Kriwacki
Journal:  EMBO J       Date:  2004-12-16       Impact factor: 11.598

7.  Geographic and temporal trends in antimicrobial nonsusceptibility in Streptococcus pneumoniae in the post-vaccine era in the United States.

Authors:  Ruth Link-Gelles; Ann Thomas; Ruth Lynfield; Sue Petit; William Schaffner; Lee Harrison; Monica M Farley; Deborah Aragon; Megin Nicols; Pam Daily Kirley; Shelley Zansky; James Jorgensen; Billie Anne Juni; Delois Jackson; Matthew R Moore; Marc Lipsitch
Journal:  J Infect Dis       Date:  2013-07-12       Impact factor: 5.226

Review 8.  A review on anti-adhesion therapies of bacterial diseases.

Authors:  Arezoo Asadi; Shabnam Razavi; Malihe Talebi; Mehrdad Gholami
Journal:  Infection       Date:  2018-10-01       Impact factor: 3.553

9.  Immunoblot method to detect Streptococcus pneumoniae and identify multiple serotypes from nasopharyngeal secretions.

Authors:  Melinda A Bronsdon; Katherine L O'Brien; Richard R Facklam; Cynthia G Whitney; Benjamin Schwartz; George M Carlone
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

10.  Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes.

Authors:  Daniel J Livorsi; Jessica R Macneil; Amanda C Cohn; Joseph Bareta; Shelly Zansky; Susan Petit; Ken Gershman; Lee H Harrison; Ruth Lynfield; Arthur Reingold; William Schaffner; Ann Thomas; Monica M Farley
Journal:  J Infect       Date:  2012-08-15       Impact factor: 6.072

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.